Abstract |
In 25 patients with spasticity, pharmacokinetics and effects of dantrolene sodium were investigated after prolonged administration. A beneficial effect occurred in seven patients. The results were better on 100 mg daily than on a higher daily dose. An increase of the daily dose from 200 to 400 mg was not associated with higher blood levels. Many side effects were noted such as: anorexia, nausea, drowsiness, depression and muscle weakness. From this study we conclude that dantrolene sodium is a muscle relaxant with a weak to moderate effect in patients with spasticity; the effect at doses higher than 200 mg daily is probably poor.
|
Authors | W J Meyler, H Bakker, J J Kok, S Agoston, H Wesseling |
Journal | Journal of neurology, neurosurgery, and psychiatry
(J Neurol Neurosurg Psychiatry)
Vol. 44
Issue 4
Pg. 334-9
(Apr 1981)
ISSN: 0022-3050 [Print] England |
PMID | 7241161
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Muscle Relaxants, Central
- Dantrolene
|
Topics |
- Adult
- Aged
- Brain Concussion
(drug therapy)
- Dantrolene
(therapeutic use)
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Middle Aged
- Multiple Sclerosis
(drug therapy)
- Muscle Relaxants, Central
(therapeutic use)
- Muscle Spasticity
(drug therapy)
- Paralysis
(drug therapy)
- Spinal Cord Diseases
(drug therapy)
|